Respiratory failure & ventilation

Inflammatory subphenotypes previously identified in ARDS are associated with mortality at intensive care unit discharge: a secondary analysis of a prospective observational study

Crit CarePublished Secondary analysis of a prospective observational cohort study

Authors' conclusion

Patients assigned to the hyperinflammatory subphenotype at ICU discharge showed significantly stronger anomalies in coagulation activation, endothelial cell activation and inflammation pathways implicated in the pathogenesis of critical disease and increased mortality until one-year follow up.

Study context

Population
Intensive care unit (ICU)-survivors discharged alive from two Dutch ICUs, 2011–2014, with plasma biomarkers availableof 8332 in original cohort
Participants
1,483 participants
Comparison
Hyperinflammatory vs Hypoinflammatory
  • Hyperinflammatoryn = 86
  • Hypoinflammatoryn = 1,397reference
Primary endpoint
Mortality after ICU discharge
Follow-up
30 days and one year
Methodological detailstwo Dutch ICUs, sensitivity analysis by latent class analysis
  • Two Dutch ICUs
  • Sensitivity analysis by latent class analysis

Primary result

As reported in the abstract

Mortality

Mortality

One-year mortality

P < 0.001

  • Hyperinflammatory vs Hypoinflammatory: P = 0.005 — 30-day mortality

Further findings

OutcomeHyperinflammatoryHypoinflammatoryP value
SOFA score at ICU discharge7 (IQR 5–9)4 (IQR 2–6)P < 0.001

Latent class analysis (sensitivity analysis)

Latent class analysis (LCA) deemed 2 subphenotypes most suitable; class 1 had significantly higher mortality than class 2; hyperinflammatory patients mainly in class 1

Original publication

Inflammatory subphenotypes previously identified in ARDS are associated with mortality at intensive care unit discharge: a secondary analysis of a prospective observational study. Crit Care. Published 7 May 2024. doi:10.1186/s13054-024-04929-9

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.